Companies
FDA expands Pharming’s Joenja approval to younger children with APDS
The approval covers children aged 4 to 11 weighing at least 27 kg. Pharming expects the newly approved doses to become available in the U.S. in October; a separate application for lower-weight children remains submitted only.